Curriculum Vitae

DR. LEE ZHENG YANG

Pharmacy Lecturer
  • Department of Pharmaceutical Chemistry
    Faculty of Pharmacy
  • leeyang

BIOGRAPHY

Dr. Lee Zheng Yang is a registered pharmacist and currently serves as a Lecturer in the Department of Pharmaceutical Chemistry at Universiti Malaya. He holds a Ph.D. in Pharmaceutical Sciences from Taylor’s University, where his research focused on drug discovery and the chemical synthesis of bioactive compounds.

Before joining academia, Dr. Lee practiced in the retail pharmacy setting, where he delivered pharmaceutical care and gained first-hand insights into patient behavior, medication compliance, and the commercial dynamics driving pharmaceutical sales. This experience strengthened his ability to bridge the gap between pharmaceutical science and real-world pharmacy practice.

He has published in peer-reviewed journals and presented his work at both local and international conferences. Dr. Lee is committed to advancing research in drug development and chemical synthesis, while also contributing to high-quality pharmacy education and preparing future pharmacists for both clinical and commercial challenges.

ACADEMIC QUALIFICATION

  • PhD (PHARMACEUTICAL SCIENCES), (PHARMACEUTICAL SCIENCES)
    Taylor's University
  • BPharm (Hons) (First Class), (Pharmacy)
    Taylor's University

PUBLICATIONS

Article in Journal
  1. Lee, Z. Y., Lee, W. H., Lim, J. S., Ali, A. A. A., Loo, J. S. E., Wibowo, A., Mohammat, M. F., & Foo, J. B. (2024). Golgi apparatus targeted therapy in cancer: Are we there yet?. Life sciences, 352, 122868. https://doi.org/10.1016/j.lfs.2024.122868
  2. Lim, D. V., Woo, W. H., Lim, J. X., Loh, X. Y., Soh, H. T., Lim, S. Y. A., Lee, Z. Y., Yow, H. Y., Hamzah, S. B., Sellappans, R., & Foo, J. B. (2024). Targeting Mutant-p53 for Cancer Treatment: Are We There Yet?. Current molecular pharmacology, 17, e140923221042. https://doi.org/10.2174/1874467217666230914090621
  3. Lim, Y. J., Clarissa Lau, P. S., Low, S. X., Ng, S. L., Ong, M. Y., Pang, H. M., Lee, Z. Y., Yow, H. Y., Hamzah, S. B., Sellappans, R., & Foo, J. B. (2023). How Far Have We Developed Antibody–Drug Conjugate for the Treatment of Cancer? Drugs and Drug Candidates, 2(2), 377-421. https://doi.org/10.3390/ddc2020020
  4. Lee, Z. Y., Leong, C. H., Lim, K. U. L., Wong, C. C. S., Pongtheerawan, P., Arikrishnan, S. A., Tan, K. L., Loh, J. S., Low, M. L., How, C. W., Ong, Y. S., Tor, Y. S., & Foo, J. B. (2022). Induction of Apoptosis and Autophagy by Ternary Copper Complex Towards Breast Cancer Cells. Anti-cancer agents in medicinal chemistry, 22(6), 1159–1170. https://doi.org/10.2174/1871520621666210726132543
  5. Lee, Z. Y., Loo, J. S. E., Wibowo, A., Mohammat, M. F., & Foo, J. B. (2021). Targeting cancer via Golgi α-mannosidase II inhibition: How far have we come in developing effective inhibitors?. Carbohydrate research, 508, 108395. https://doi.org/10.1016/j.carres.2021.108395